Skip to main content

Dr. Malik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Malik's full profile

Already have an account?

  • Office

    8701 Watertown Plank Rd
    Hub for Collaborative Medicine, 8th Floor
    Milwaukee, WI 53226
    Phone+1 414-955-0437
    Fax+1 414-955-0093

Summary

  • Dr. Anuj Malik is currently pursuing a Critical Care Fellowship at the Medical College of Wisconsin in Milwaukee. He was previously an Infectious Disease specialist based in Tulsa, OK with a monthly rotating assignment at a residency program in Fresno CA as ID faculty for the Internal Medicine Residency program at St. Agnes Medical Center. He completed his Infectious Disease fellowship at the University of New Mexico School of Medicine from 2012 to 2014. His earlier training includes an Internal Medicine internship at Jewish Hospital of Cincinnati, followed by a residency at Abington Memorial Hospital. He also completed a year of immune compromised host Infectious diseases at Baylor College of Medicine and MD Anderson Medical Center. Dr. Malik earned his MD from Jawaharlal Nehru Medical College in 2000. He has contributed to the medical literature, with publications on topics such as the association between pulmonary artery pressures and atrial fibrillation post-lung transplantation. He has also published on Fostamatinib and was the Principal Investigator for numerous clinical trials at the Ascension St. John Medical Center in Tulsa, OK. He was honored as a Gold Medalist at ACPM Medical College in 1995 and by the Medalsformettle foundation for his work in the COVID pandemic in his community in Tulsa. He was very active during COVID in his community and in addition to being PI for numerous studies, was featured in the local and national media multiple times. For fun, he also was an obesity medicine doctor on TLC's "Family by the ton" show's first season. In his spare time, he likes to bike, play tennis and tinker with his guitar at home.

Education & Training

  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Infectious Disease, 2012 - 2014
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Infectious Disease, 2010 - 2011
  • Abington Memorial Hospital
    Abington Memorial HospitalResidency, Internal Medicine, 2006 - 2008
  • Jewish Hospital of Cincinnati
    Jewish Hospital of CincinnatiInternship, Internal Medicine, 2005 - 2006
  • Jawaharlal Nehru Medical College
    Jawaharlal Nehru Medical CollegeClass of 2000, MD

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2027
  • CA State Medical License
    CA State Medical License 2008 - 2026
  • OK State Medical License
    OK State Medical License 2019 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • WI State Medical License
    WI State Medical License 2024 - 2025
  • NM State Medical License
    NM State Medical License 2012 - 2015
  • PA State Medical License
    PA State Medical License 2006 - 2008
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease
  • Obesity Medicine
    American Board of Obesity Medicine Obesity Medicine
  • Join now to see all

Awards, Honors, & Recognition

  • Gold Medalist ACPM Medical College, 1995

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase 3 Trial of the SYK inhibitor Fostamatinib in patients hospitalized with COVID 19: Protocol and Study Implementation Updates  
    Lucy Yan, Ziad Mallat, Suzanna Lobo, Anuj Malik, OFID, 12/2/2022

Abstracts/Posters

  • Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia
    Ziad Mallat, Suzana Lobo, Anuj Malik, Sandra Tong, Open Forum Infectious Disease, 12/4/2021

Lectures

  • A review of long term efficacy and safety data with Fostamatinib 
    4/13/2022

Press Mentions

  • Can Rigel’s Bleeding Disorder Drug Fostamatinib Cross over into Covid-19?
    Can Rigel’s Bleeding Disorder Drug Fostamatinib Cross over into Covid-19?November 1st, 2021
  • Local Health Leaders Embrace CDC Mask Guidance Amid COVID Surge; Bynum Says No Mandate Coming
    Local Health Leaders Embrace CDC Mask Guidance Amid COVID Surge; Bynum Says No Mandate ComingAugust 7th, 2021
  • No Mask Order, but Tulsa Mayor Urges End to Vaccine-Hesitancy with Hospital Leaders' Guidance
    No Mask Order, but Tulsa Mayor Urges End to Vaccine-Hesitancy with Hospital Leaders' GuidanceAugust 6th, 2021
  • Join now to see all

Other Languages

  • Hindi